Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: A pilot study
Aim Until now, no effective adjuvant therapy to prevent early recurrence of hepatocellular carcinoma (HCC) after curative treatment has been reported. The aim of this study is to evaluate the clinical benefit of sorafenib as adjuvant treatment in subjects with HCC after hepatic resection. Methods Th...
Saved in:
Published in | Hepatology research Vol. 44; no. 5; pp. 523 - 531 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Blackwell Publishing Ltd
01.05.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!